The global Legionella Testing Market size is expected to value at USD 352.6 million by 2025. The market is subject to witness a substantial growth due to the growing prevalence of legionella-based disorders coupled with increasing awareness among general population in regards to their preventive management. Legionella can lead to legionellosis, which is a respiratory disorder, also known as a pneumonia.

Treatment of legionellosis involves intensive care and hospitalization, and comes under the public health concerns. As per recent reports, as many as 4,568 cases were registered of Legionnaires’ disease in the last one years. Globally, the legionella testing industry is predicted to grow at CAGR of 8.4% in the forecast period, providing numerous opportunities for market players to invest for research and development in the market.

Legionella bacteria are particularly found in the hot water conditions. Numerous industries with high requirement for water are likely susceptible towards development of aquatic legionella. In addition, contamination of the water with legionella in public places such as schools, restaurants, hospitals, and large plumbing systems can lead to widespread disease. These factors are influencing the demand for legionella testing market.

Moreover, high-end demand from various end-user industries for accurate and on-time diagnosis of Legionella and related infections is expected to boost the growth of legionella testing industry. Water testing for legionella is carried out in a certified microbiology lab along with well-characterized and validated methods. Legionella pneumophila group is considered as the most pathogenic or disease spreading strain of Legionella bacteria.

Furthermore, various testing for Legionnaire disease performed by healthcare professionals are vital, particularly patients that are diagnosed in the past 12 months. Certain water conditions that can lead to legionella growth include low chlorine levels in water, leading to environmental testing to be conducted every two months. These factors are expected to fuel the market demand for legionella testing over the forecast period. Legionnaire’s disease outbreaks commonly occur in various traveling spots such as hotels, resorts, or cruise ships, and in some instances healthcare facilities. Increasing healthcare expenditure, particularly in the developed economies across the globe is anticipated to foster market growth over the next seven years.

The legionella testing market is broadly categorized into two major segments based on the application type such as water testing and IVD (In Vitro Diagnostic) testing. The water testing is considered as one of the fastest growing segment in the market of legionella testing with substantial revenue generation in the last few years. Growing popularity of the legionella testing is attributed to the favorable laws & regulation by local governments coupled with introduction of precise diagnostic methods. The water-testing segment is further categorized into multiple sub-segments such as microbial culture, DFA Stain, PCR segment. The IVD (In Vitro Diagnostic) testing segment has also witnessed substantial growth owing to the rising demand for urine antigen tests.

Request a Free Sample Copy of Legionella Testing Market Report @ https://www.millioninsights.com/industry-reports/legionella-testing-market/request-sample

The legionella testing industry is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in the implementation of latest technologies in medicine & pharmaceutical sector, massive increase in the geriatric population, significant market penetration and existence of well-established healthcare infrastructure in the region.

Asia-Pacific region is predicted to hold major market share in the legionella testing market with massive growth in forecast period. Countries such as India, China and Malaysia are leading the Asia-Pacific market with increasing healthcare expenditure, growing prevalence of legionella-based disorders, rising per capita income and significant investment by leading industry players considering potential growth opportunities in the region.

The key players in the legionella testing industry are Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Alere, Inc., Roche Diagnostics Co., Thermo Fischer Scientific, Inc., and Becton, Dickinson (BD) and Co.

Market Segment:

Legionella Testing Application Outlook (Revenue, USD Million, 2013 - 2025)
• Water Testing
• Microbial Culture
• DFA Stain
• PCR
• Others
• IVD Testing
• Blood Culture
• Urine Antigen Test
• DFA Stain
• PCR
• Others

Browse the Full Global Legionella Testing Market - Global Scenario, Industry Outlook, Analysis, Size, Trends and Forecast, 2013 To 2025 Report at - https://www.millioninsights.com/industry-reports/legionella-testing-market

Legionella Testing Regional Outlook (Revenue, USD Million, 2013 - 2025)
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• India
• Latin America
• Brazil
• Mexico
• Middle East and Africa (MEA)
• South Africa

22 March 2019, The Global Legionella Testing Market is expected to grow at a considerable rate over the forecast period owing to the advancements and automation in the immunodiagnostic market such as the introduction of advanced ELISA antibodies for the prevention of legionnaires diseases in the market. The rapidly rising awareness about legionella based diseases and the increase in demand for advanced immunodiagnostic techniques is a direct consequence of rapidly increasing incidences of mild flu and pneumonia like diseases through legionella bacteria. Since legionella bacteria requires the presence of iron and cysteine to grow, it is traditionally detected by culture on buffered charcoal yeast extract. This process takes 4 to 5 days for detecting the legionella bacteria. The advanced immunological techniques such as polymerase chain reaction and rapid immunological assays are efficient to detect the legionella bacteria in few minutes. These techniques are commonly used to establish the presence of species of Legionella bacteria in the sample. Some of the other drivers for the growth of the global legionella testing market include the entry of new players, new emerging economies such as China and India and increase in the funding for healthcare facilities by the government in many regions. There are about 40 different species of legionella bacteria out of which 18 species are infectious. Among all these species, the legionella pneumophilla bacterium can cause most of the diseases. Many hospitals have started various tests such as legionella urinary antigen test for the initial detection of legionella based diseases. This is the factor expected to further fuel the legionella testing market over the forecast period.

The legionella testing market has been divided on the basis of antibiotics used for the treatment of legionella infections into rifampin, azithromycin, ketolides, quinolones and macrolides. It is expected that Azithromycin drug will grow at the fastest rate throughout the forecast period owing to its efficiency to treat legionella based diseases. Azithromycin drug is mainly used for treating this infection in children and adults. The increasing incidences of legionella based diseases in children and adults is also a factor driving the Azithromycin drug segment in the market. Apart, certain flouroquinolones such as moxifloxacin and levofloxacin are also considered as the most efficient drugs for legionella based diseases. There are several diagnostic tests which are available commercially in the market for initial detection of Legionella bacteria in the body such as sputum or lung tissue test, urine antigen test, chest X-ray and blood test. There are various end users of legionella testing drugs which include hospitals, commercial or private labs, physician offices and public health labs.

Browse Details of Report @ https://www.hexaresearch.com/research-report/legionella-testing-industry

Major regions estimated for the legionella testing market are North America, Europe, Asia Pacific and RoW. As of 2013, North America dominated the market attributing the largest share in terms of revenue. This large share can be accounted for by the increasing number of patients suffering from legionella based diseases, the presence of large number of market players and government initiatives such as various public health labs across the region. Owing to the new emerging economies such as Germany and U.K. and rising awareness about legionella based diseases in the Europe region, it is expected that this region will show lucrative growth in the global legionella testing market over the forecast period.

The key participants in the legionella testing market include Roche Diagnostics, Beckman Coulter, Bio Rad, Novartis Diagnostics, Life Technology, Becton Dickinson, Abott laboratories, Eiken Chemical, ID Biomedical, Thermo Fischer, Takara Bio, Kreatech, Gen Probe, Enzo Biochem and SeraCare. The market leaders in the global legionella testing market are involved in continuous efforts for the development of innovative methodologies of testing which would increase the efficiency and accuracy of test results while providing the smooth processing of larger samples simultaneously. This companies are also entering into strategic collaborations and expansions to extend their global patient base.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry